Darunavir Tablet, Film Coated
Product Images NDC 72578-147

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Darunavir (NDC 72578-147). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Viona Pharmaceuticals Inc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image (De3be678 A82f 4052 B7ce 728d887d548e 01)

FDA Label Image

Image (De3be678 A82f 4052 B7ce 728d887d548e 02)

FDA Label Image

Image (De3be678 A82f 4052 B7ce 728d887d548e 03)

FDA Label Image

Image (De3be678 A82f 4052 B7ce 728d887d548e 04)

Image (De3be678 A82f 4052 B7ce 728d887d548e 04)
This is a description of a medication package containing Darunavir tablets with a dosage of 800 mg. The package includes 30 film-coated tablets with a child-resistant feature. The recommended storage temperature is between 20°C to 25°C (68°F to 77°F) with excursions allowed between 15°C to 30°C (59°F to 86°F). The tablets should be kept out of the reach of children. The medication is manufactured by Zydus Lifesciences Ltd in India and distributed by Viona Pharmaceuticals Inc. in Cranford, NJ. The NDC number is 72578-148-06.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.